BPC-157
Recovery Research
Strength
5 mg
Purity
99.4%
- High purity
- Batch tested
- COA available
Category
Tissue repair, actin regulation and barrier-integrity peptides.
Recovery-class research peptides are studied for their roles in cell migration, angiogenesis, actin dynamics and epithelial barrier integrity. The best-characterised members — BPC-157 and TB-500 — act through genuinely different mechanisms despite being frequently grouped together in secondary sources.
These compounds are supplied for in vitro and preclinical laboratory research only. They are not therapeutics, they carry no approved indication, and they must not be administered to humans or animals.
Recovery Research
Strength
5 mg
Purity
99.4%
Recovery Research
Strength
10 mg
Purity
99.4%
Recovery Research
Strength
20 mg
Purity
99.4%
Recovery Research
Strength
5 mg
Purity
99.1%
Recovery Research
Strength
10 mg
Purity
99.1%
Recovery Research
Strength
20 mg
Purity
99.1%
Recovery Research
Strength
50 mg
Purity
99.6%
Recovery Research
Strength
100 mg
Purity
99.6%
Recovery Research
Strength
5 mg
Purity
99.3%
Recovery Research
Strength
10 mg
Purity
99.3%
Recovery Research
Strength
2 mg
Purity
99.3%
Recovery Research
Strength
5 mg
Purity
99.3%
Recovery Research
Strength
5 mg
Purity
98.9%
Recovery Research
Strength
10 mg
Purity
98.9%
Growth Hormone Research
Strength
1 mg
Purity
98.8%
Growth Hormone Research
Strength
2 mg
Purity
99.0%
Longevity & Cellular Research
Strength
5 mg
Purity
99.0%
Longevity & Cellular Research
Strength
10 mg
Purity
99.0%
Specialty Research
Strength
50 mg + 5 mg
Purity
99.4%
Specialty Research
Strength
5 mg + 5 mg
Purity
99.2%
Recovery Research
Strength
10 mg + 10 mg + 50 mg
Purity
99.3%
Recovery Research
Strength
10 mg + 10 mg
Purity
99.3%
Specialty Research
Strength
1 mg
Purity
99.0%
Recovery Research
Strength
16 mg
Purity
99.0%
Longevity & Cellular Research
Strength
20 mg
Purity
98.8%
Skin & Hair
Strength
100 mg
Purity
99.4%
Skin & Hair
Strength
70 mg
Purity
99.2%
Skin & Hair
Strength
80 mg
Purity
99.2%
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in gastric juice. Published in vitro work associates it with fibroblast migration, growth-factor receptor expression and nitric-oxide pathway modulation. It is a short, unmodified sequence and is correspondingly well-behaved in chromatography.
TB-500 is the synthetic acetylated fragment corresponding to the active region of thymosin beta-4, and its studied mechanism is actin sequestration — binding G-actin monomers and influencing cytoskeletal assembly and cell motility. Full-length thymosin beta-4 is a longer, separately supplied molecule and should not be treated as interchangeable with the fragment.
KPV is a tripeptide C-terminal fragment of alpha-MSH studied in epithelial and inflammatory-signalling models, and GHK-Cu is a copper-binding tripeptide studied in matrix remodelling. Both are frequently grouped into recovery research despite belonging to different structural families.
GHK-Cu is supplied as a copper complex and has a characteristic blue colouration in solution — that colour is expected, not contamination. It should not be co-dissolved with chelating buffers, which will strip the copper and change the species entirely.
Short unmodified sequences such as BPC-157 and KPV dissolve readily but are more susceptible to microbial degradation in non-preserved diluent. Where sterility over a working window matters, preserved diluent and refrigerated storage are standard practice.
This category contains several fragment-versus-parent pairs: TB-500 against thymosin beta-4, and thymosin alpha-1 as a separate immunological sequence. Because fragments and parents differ substantially in mass, mass spectrometry is the reliable discriminator, and every recovery-class lot is released against independent MS confirmation.
All compounds listed on this page are supplied for laboratory research use only. They are not drugs, supplements or cosmetics, and are not intended for human or veterinary consumption. See our research use policy.